References
- Walker A E, Robins M, Weinfeld F D. Epidemiology of brain tumours: the national survey of intracranial neoplasms. Neurology 1985; 35: 219–226
- Lacroix M, Abi-Said D, Fourney D R, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 2001; 95: 190–198
- Mineo J F, Bordron A, Baroncini M, et al. Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir (Wien) 2007; 149(3)245–253
- Yuile P, Dent O, Cook R, Biggs M, Little N. Survival of glioblastoma patients related to presenting symptoms, brain site and treatment variables. J Clin Neurosci 2006; 13: 747–751
- Stark A M, Nabavi A, Mehdorn H M, Blfmer U. Glioblastoma multiforme report of 267 cases treated at a single institution. Surg Neurol 2005; 63: 162–169
- Albert F K, Forsting M, Sartor K, Adams H P, Kunze S. Early postoperative magnetic resonance imaging after resection of malignant glioma: objective evaluation of residual tumour and its influence on regrowth and prognosis. Neurosurgery 1994; 34: 45–60
- Willems P WA, Taphoorn M JB, Burger H, Sprenkel V D, Tulleken C AF. Effectiveness of neuronavigation in resecting solitary intracerebral contrast-enhancing tumours: a randomized controlled trial. J Neurosurg 2006; 104: 360–368
- Schneider S W, Ludwig T, Tatenhorst L, et al. Glioblastoma cells release factors that disrupt blood-brain barrier features. Acta Neuropathol (Berl.) 2004; 107: 272–276
- Shinoda J, Yano H, Yoshimura S, Okumura A, Kaku Y, Sakai N. Fluorescence-guided resection of glioblastoma multiforme by using high-dose fluorescein sodium. Technical note. J Neurosurg 2003; 99: 597–603
- Stummer W, Novotny A, Step H, Goetz C, Bise K, Reule H J. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients. J Neurosurg 2000; 93: 1003–1013
- Stummer W, Pichlmeier U, Meinel T, Wiestler O D, Zanella F, Reulen H J. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 2006; 7(5)392–401
- Kuroiwa T, Kajimoto Y, Ohta T. Development of a fluorescein operative microscope for use during malignant glioma surgery. A technical note and preliminary report. Surg Neurol 1998; 50: 41–49
- Hammoud M A, Ligon B L, ElSouki R, Shi W M, Schomer D F, Sawaya R. Use of intraoperative ultrasound for localizing tumours and determining the extent of resection: a comparative study with magnetic resonance imaging. J Neurosurg 1996; 84: 737–741
- Litofsky N S, Bauer A M, Kasper R S, Sullivan C M, Dabbous O H. Image-guided resection of high-grade glioma: patient selection factors and outcome. Neurosurg Focus 2006; 20(3)E16
- Knauth M, Wirtz C R, Tronnier V M, Aras N, Kunze S, Sartor K. Intraoperative MR Imaging increases the extent of tumour resection in patients with high-grade gliomas. AJNR Am J Neuroradiol 1999; 20: 1642–1646